HAEMONETICS CORP (HAE)
About HAEMONETICS CORP
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2026
- $1.3B
- Net income
- $97.3M
- Total assets
- $2.4B
- Market cap
- $3.6B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $3.6B
- Shares outstanding
- 30.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 9, 1991
Haemonetics Corp (HAE) Stock Price
- Profitable — net income of $97.3M in FY2026.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review HAEMONETICS CORP.
Write a review
News about HAEMONETICS CORP
News & sentiment via Polygon.io
Haemonetics Corp: frequently asked questions
Is Haemonetics Corp an American company?
Haemonetics Corp is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Haemonetics Corp headquartered?
Haemonetics Corp is headquartered in Boston, Massachusetts, United States.
Is Haemonetics Corp publicly traded?
Yes — Haemonetics Corp is a publicly traded company. Its stock trades under the ticker symbol HAE on the NYSE.
What does Haemonetics Corp do?
Haemonetics Corp is an American Medical Devices company in the Health & Beauty sector.
